BeOne Medicines Ltd. (ONC) operating KPIs
ONCNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as BEIGF
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026Score 12/302313% above fair value
$370.33−1.23 (-0.33%)
Close on Oct 30, 2026Market cap $42.11BP/E 66.2Yield –
BeOne Medicines 2016 Plan — Share Options Granted During Month (options)
HKEX Form FF301 Monthly Returns (06160.HK)
Latest, Sep 2026
682,266
Period ended Sep 28, 2026
Change on a year earlier
+34.0%
509,197 in Sep 2025
History
51 months
Since Jul 2021
Sources
51
Documents cited below
Monthly history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | 2016 Plan — Share Options Granted During Month (options) | Year on year | Source |
|---|---|---|---|---|
| Sep 2026 | Sep 28, 2026 | 682,266 | +34.0% | HKEX FF301 (2026-09) ↗ |
| Aug 2026 | Aug 28, 2026 | 906,269 | -1.6% | HKEX FF301 (2026-08) ↗ |
| Jul 2026 | Jul 28, 2026 | 434,044 | – | HKEX FF301 (2026-07) ↗ |
| Jun 2026 | Jun 28, 2026 | 23,359,557 | -12.5% | HKEX FF301 (2026-06) ↗ |
| May 2026 | May 28, 2026 | 330,668 | -82.0% | HKEX FF301 (2026-05) ↗ |
| Mar 2026 | Mar 28, 2026 | 505,375 | -46.5% | HKEX FF301 (2026-03) ↗ |
| Jan 2026 | Jan 28, 2026 | 273,442 | -80.7% | HKEX FF301 (2026-01) ↗ |
| Dec 2025 | Dec 28, 2025 | 693,186 | +41.3% | HKEX FF301 (2025-12) ↗ |
| Nov 2025 | Nov 28, 2025 | 490,581 | -60.6% | HKEX FF301 (2025-11) ↗ |
| Sep 2025 | Sep 28, 2025 | 509,197 | -65.4% | HKEX FF301 (2025-09) ↗ |
| Aug 2025 | Aug 28, 2025 | 921,323 | -62.7% | HKEX FF301 (2025-08) ↗ |
| Jun 2025 | Jun 28, 2025 | 26,684,619 | -44.9% | HKEX FF301 (2025-06) ↗ |
| May 2025 | May 28, 2025 | 1,833,546 | +2.2% | HKEX FF301 (2025-05) ↗ |
| Mar 2025 | Mar 28, 2025 | 943,839 | +22.6% | HKEX FF301 (2025-03) ↗ |
| Jan 2025 | Jan 28, 2025 | 1,413,659 | +20.9% | HKEX FF301 (2025-01) ↗ |
| Dec 2024 | Dec 28, 2024 | 490,620 | +1.5% | HKEX FF301 (2024-12) ↗ |
| Nov 2024 | Nov 28, 2024 | 1,245,296 | -12.6% | HKEX FF301 (2024-11) ↗ |
| Sep 2024 | Sep 28, 2024 | 1,472,315 | -4.1% | HKEX FF301 (2024-09) ↗ |
| Aug 2024 | Aug 28, 2024 | 2,469,168 | +17.7% | HKEX FF301 (2024-08) ↗ |
| Jun 2024 | Jun 28, 2024 | 48,463,857 | +36.5% | HKEX FF301 (2024-06) ↗ |
| May 2024 | May 28, 2024 | 1,794,767 | +25.1% | HKEX FF301 (2024-05) ↗ |
| Mar 2024 | Mar 28, 2024 | 769,548 | +27.4% | HKEX FF301 (2024-03) ↗ |
| Feb 2024 | Feb 28, 2024 | 998,946 | +40.3% | HKEX FF301 (2024-02) ↗ |
| Jan 2024 | Jan 28, 2024 | 1,169,376 | +97.6% | HKEX FF301 (2024-01) ↗ |
| Dec 2023 | Dec 28, 2023 | 483,366 | +12.3% | HKEX FF301 (2023-12) ↗ |
| Nov 2023 | Nov 28, 2023 | 1,424,735 | +100.3% | HKEX FF301 (2023-11) ↗ |
| Sep 2023 | Sep 28, 2023 | 1,535,885 | -5.3% | HKEX FF301 (2023-09) ↗ |
| Aug 2023 | Aug 28, 2023 | 2,098,252 | +49.7% | HKEX FF301 (2023-08) ↗ |
| Jun 2023 | Jun 28, 2023 | 35,508,993 | -8.2% | HKEX FF301 (2023-06) ↗ |
| May 2023 | May 28, 2023 | 1,434,277 | -14.0% | HKEX FF301 (2023-05) ↗ |
| Mar 2023 | Mar 28, 2023 | 603,954 | -42.7% | HKEX FF301 (2023-03) ↗ |
| Feb 2023 | Feb 28, 2023 | 712,127 | -31.7% | HKEX FF301 (2023-02) ↗ |
| Jan 2023 | Jan 28, 2023 | 591,825 | -67.1% | HKEX FF301 (2023-01) ↗ |
| Dec 2022 | Dec 28, 2022 | 430,430 | -33.4% | HKEX FF301 (2022-12) ↗ |
| Nov 2022 | Nov 28, 2022 | 711,386 | +3.9% | HKEX FF301 (2022-11) ↗ |
| Oct 2022 | Oct 28, 2022 | 626,808 | +36.6% | HKEX FF301 (2022-10) ↗ |
| Sep 2022 | Sep 28, 2022 | 1,621,568 | +53.3% | HKEX FF301 (2022-09) ↗ |
| Aug 2022 | Aug 28, 2022 | 1,401,543 | +14.9% | HKEX FF301 (2022-08) ↗ |
| Jul 2022 | Jul 28, 2022 | 1,135,940 | +18.8% | HKEX FF301 (2022-07) ↗ |
| Jun 2022 | Jun 28, 2022 | 38,701,468 | – | HKEX FF301 (2022-06) ↗ |
| May 2022 | May 28, 2022 | 1,666,886 | – | HKEX FF301 (2022-05) ↗ |
| Apr 2022 | Apr 28, 2022 | 1,200,082 | – | HKEX FF301 (2022-04) ↗ |
| Mar 2022 | Mar 28, 2022 | 1,054,495 | – | HKEX FF301 (2022-03) ↗ |
| Feb 2022 | Feb 28, 2022 | 1,042,028 | – | HKEX FF301 (2022-02) ↗ |
| Jan 2022 | Jan 28, 2022 | 1,800,526 | – | HKEX FF301 (2022-01) ↗ |
| Dec 2021 | Dec 28, 2021 | 646,139 | – | HKEX FF301 (2021-12) ↗ |
| Nov 2021 | Nov 28, 2021 | 684,424 | – | HKEX FF301 (2021-11) ↗ |
| Oct 2021 | Oct 28, 2021 | 458,822 | – | HKEX FF301 (2021-10) ↗ |
| Sep 2021 | Sep 28, 2021 | 1,058,070 | – | HKEX FF301 (2021-09) ↗ |
| Aug 2021 | Aug 28, 2021 | 1,220,102 | – | HKEX FF301 (2021-08) ↗ |
| Jul 2021 | Jul 28, 2021 | 956,033 | – | HKEX FF301 (2021-07) ↗ |
Cite this data
StockData. (2026). BeOne Medicines 2016 Plan — Share Options Granted During Month (options), monthly Jul 2021–Sep 2026 [Data set]. Compiled from BeOne Medicines SEC filings and investor materials. https://stockdatahq.com/stocks/onc/kpis/hkex_opt_granted
See every metric in the BeOne Medicines KPI table. Data updated Oct 29, 2026.